Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP654958.RAstDMAwUeirmdNBcpto3rB6QpXaALdh9iYj7ZRbQcRqk130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654958.RAstDMAwUeirmdNBcpto3rB6QpXaALdh9iYj7ZRbQcRqk130_provenance.
• NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435223.RAPu34-rfSXPn52k8n5MYk2-X9eMSqRnL8zaFq82Ud-Jk130_provenance.
• assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP906293.RAemUBQl-JfiHcQJTrtxqFEtY2p0RFIPDIg1afkwkzoJU130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906293.RAemUBQl-JfiHcQJTrtxqFEtY2p0RFIPDIg1afkwkzoJU130_provenance.
• NP906297.RAenLRLNqaqzEOp-R8D8sEA3TCl0GvT3v_fZaUfxXxXwg130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906297.RAenLRLNqaqzEOp-R8D8sEA3TCl0GvT3v_fZaUfxXxXwg130_provenance.
• NP906292.RAracq2x2FFSSpUss6QhTFudPm7qT-ti_3agGrX1HlWqI130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906292.RAracq2x2FFSSpUss6QhTFudPm7qT-ti_3agGrX1HlWqI130_provenance.
• NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_provenance.
• NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288316.RAMPQNHYmka_iKzXPbwg9r--AbZR2NbK894cj8f-5MS-k130_provenance.
• NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906295.RAFC0w-YkH1oK1uWaDFRtxfnWwYZvoiqN2-HaGL3IBRSQ130_provenance.